
Luca Stocchi MD,MBA
@lucastocchimd
Chair, Division of #ColorectalSurgery at @MayoClinic. #IBD expert. Tweets = mine. #MayoClinicFL
ID: 913393295220453376
https://www.mayoclinic.org/ 28-09-2017 13:21:46
151 Tweet
736 Followers
61 Following


.Justin Brady on when and when not to do Hartmann. Patient selection is key. Sometimes it’s still necessary. But better stoma free survival without. Mayo Clinic #MayoISS25.




Excellent Annals of Surgical Oncology study from MD Anderson Cancer Center Emory Surgery looking at predictors for local recurrence after #WatchandWait for rectal cancer: +EMVI associated with an increased risk of local recurrence after cCR (44%) +LPLNs also had increased recurrence (47%) ---If tumor








Pitt Surgery is now the best residency program in the nation. True pioneers in ranking & matching the best with no discrimination. 5/7 of their matched interns are IMGs. Programs that still "do not take IMGs" as categorical: time to step up & meet the 21st century! #Match2025


NSQIP study examining trends in surgical management of rectal prolapse in pts ≥ 70 years old--how are approaches changing? #DCRJournal discusses: bit.ly/3RjktzK Sean Langenfeld Neil Smart Matthew Albert Sami A. Chadi MD Ramon Brown, MD, MBA Sharon L. Stein Mark Soliman, MD, MBA Rahila Essani MD FACS FASCRS


Amazing work! Perfect example of multidisciplinary care. Curing the incurable and making the unresectable resectable - #Colorectal #Transplant #Oncology #Hepatology. Mayo Clinic Comprehensive Cancer Center Kristopher Croome David Larson, MD MBA Eric J. Dozois Jeremy Jones Luca Stocchi MD,MBA



Mayo Clinic Florida Gastroenterology & Hepatology is a proud partner of the Crohn's & Colitis Foundation and the takesteps #takestepsforacure walk each year We are stronger as a team and the team showed up today in numbers at the Northeast Florida Take Steps walk What do you take steps for?


This is the most important study you'll see on twitter today. I'm swamped with other work, but I had to read it. Fascinating NEJM article from Memorial Sloan Kettering Cancer Center with Longer-term data (and more patients): 6 months of single-agent immunotherapy for MMR-deficient rectal cancers,

What I heard at Grand Rounds V. Liana Tsikitis -4 subtypes of CRC. Early onset CRC is not a unique subtype -TME Immune profiling different for EOCRC -early exposures + diet + microbiome + immunity/imflammation/obesity=EOCRC -normal mucosa, NOT fecal microbiome predicts adenoma formers
